Industry News
Feature: In vino veritas
A bold sequencing project hopes to reveal the genetic basis for variation in Chardonnay grapes. And it might even lead to better wine. [ + ]
ResMed stock bounce on record quarterly profit
ResMed (ASX:RMD) shares up following 12% increase in FY12 profit, on the back of another quarter of record revenue and net income. [ + ]
New research could increase blood supplies for transfusions
A team of scientists from Albert Einstein College of Medicine in the Bronx, NY, has developed methods to increase the production of red blood cells from stem cells - a discovery that could dramatically boost the blood supply available for transfusions. [ + ]
Sirtex to triple US manufacturing capacity
Sirtex (ASX:SIR) will spend $4m over the next 18 months to expand threefold its US manufacturing capacity for SIR-Spheres doses. [ + ]
Brian McNamee to step down from CSL next July
CSL's (ASX:CSL) CEO for the last 22 years, Dr Brian McNamee, will hand the reins to successor Paul Perrault in July 2013. [ + ]
Hendra relative could help combat the deadly virus
A new benign virus related to Hendra and Nipah viruses could yield insights into what makes the latter deadly and open possibilities of new treatments or vaccines. [ + ]
Gardasil vaccine may offer protection from prostate cancer
Vaccinating young males against human papilloma virus might not only slow the spread of the virus and cervical cancer in women, but may also help protect men from prostate cancer. [ + ]
AusBiotech responds to NSW’s draft Manufacturing Industry Action Plan
AusBiotech has undertaken extensive consultation with its NSW medical technology members through an open consultation forum and private meetings and responded to the draft NSW Manufacturing Industry Action Plan. [ + ]
Kavanagh lends marketing experience to Nanosonics’ board
Newly-appointed Nanosonics (ASX:NAN) director Michael Kavanagh will offer his experience introducing new products into the healthcare market in order to see the company succeed on the world stage. [ + ]
Start-up gets backing for stroke rehab tool
UniQuest's latest start-up SMART Arm has secured investment support to launch its eponymous product, a device for improving arm function in stroke victims. [ + ]
Lifting malaria’s deadly veil: mystery solved in quest for vaccine
Researchers at the Burnet Institute have made a major breakthrough in the quest for a vaccine against malaria, which causes up to one million deaths each year. [ + ]
Bioniche developing synthetic cow fertility product
Bioniche Life Sciences (ASX:BNC) could be on the road to developing the world's first entirely synthetic FSH product for increasing fertility rates in cows, proof-of-concept stage data suggests. [ + ]
Vale Professor Ralph Slayter AC, Australia’s first Chief Scientist
Australia’s first Chief Scientist, Professor Ralph Slatyer AC, sadly passed away last week at the age of 83. Born and raised in Perth, Professor Slatyer contributed a great deal to Australian science and left behind a lasting legacy. [ + ]
pSivida signs first evaluation deal for eye treatment
pSivida (ASX:PVA) has scored another deal this week, with a major biopharmaceutical company signing up to evaluate the company's Tethadur opthalmic technology. [ + ]
New ASX listing rules to support maturing biotechs
As part of a range of initiatives to improve the competitiveness of Australia’s financial markets, the Australian Securities Exchange (ASX) has finalised new listing rules to help make it easier for small to medium size companies to raise capital for investment. [ + ]
